Study finds migraine drug to reduce depressive symptoms in patients having both

NEW DELHI: A migraine drug has shown to significantly reduce symptoms of depression in patients — the first trial to show improvements in both the conditions using a single drug, researchers said.

In the study involving 540 patients, ‘fremanezumab’ was found to reduce days of migraine in a month and symptoms of depression, compared to a placebo (inactive substance producing no effects). The drug, administered as an injection beneath the skin (subcutaneous), is available in India.

Published in The Journal of the American Medical Association (JAMA) Neurology, the study is the first to demonstrate significant improvements in migraine and depressive symptoms — often seen to co-exist in patients — with a single drug, the researchers, including those from Albert Einstein College of Medicine, US, said.

Source: PTI News

Digitalmitra